SCHEMBL7979634

SCHEMBL7979634

Cc1ccc(-c2cccc(-c3nc(-c4cccs4)c(NC(=O)c4ccccc4)o3)c2O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ADCY1 Q08828 1/20 0.45
MAPT P10636 6/20 0.45
CYP3A4 P08684 3/20 0.43
CYP2C19 P33261 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
KDM4E B2RXH2 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 4/20 0.43
HTT P42858 3/20 0.43
MAPK1 P28482 3/20 0.43
GAA P10253 2/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GFER P55789 1/20 0.42
GABRD O14764 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRA4 P48169 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981592 0.91 ADCY1 (0.45) MEN1KMT2AADCY1MAPTKDM4E
SCHEMBL7982881 0.90 ADCY1 (0.50) MEN1KMT2AADCY1MAPTKDM4E
SCHEMBL7980770 0.88 KDR (0.46) MEN1KMT2AMAPTCYP3A4CYP2C19
SCHEMBL7986016 0.86 KDR (0.46) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL7744781 0.81 ADCY1 (0.47) MEN1KMT2AADCY1MAPTCYP3A4
SCHEMBL7981622 0.80 KDR (0.44) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL7986674 0.80 KDR (0.45) MEN1KMT2AMAPTCYP2C19CYP1A2
SCHEMBL7979899 0.79 KDR (0.52) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL7986529 0.77 KDR (0.44) MEN1KMT2AADCY1MAPTCYP3A4
SCHEMBL7969458 0.77 KDR (0.46) MEN1KMT2AMAPTCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed